MSGR
MSGR
About Direxion mRNA ETF
The fund, under normal circumstances, invests at least 80% of its assets in the securities that comprise the index or investments with economic characteristics similar to the securities included in the index. The index provides exposure to the performance of companies, publicly listed in the United States, Canada and Europe, that are leading the development and application of messenger RNA...
About Direxion mRNA ETF
The fund, under normal circumstances, invests at least 80% of its assets in the securities that comprise the index or investments with economic characteristics similar to the securities included in the index. The index provides exposure to the performance of companies, publicly listed in the United States, Canada and Europe, that are leading the development and application of messenger RNA...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 VRTX | Vertex Pharmaceuticals Incorporated | 8.09% | 769 | $253.12K |
 ARCT | Arcturus Therapeutics Holdings Inc. | 7.45% | 8.67K | $233.02K |
 SCLX | Scilex Holding Company | 6.81% | 17.43K | $213.21K |
 ALNY | Alnylam Pharmaceuticals, Inc. | 6.44% | 994 | $201.64K |
 PTCT | PTC Therapeutics, Inc. | 6.31% | 3.67K | $197.43K |
 BNTX | BioNTech SE | 5.76% | 1.49K | $180.20K |
 MRNA | Moderna, Inc. | 5.59% | 1.24K | $175.01K |
 SRPT | Sarepta Therapeutics, Inc. | 5.30% | 1.31K | $165.79K |
 MRVI | Maravai LifeSciences Holdings, Inc. | 4.93% | 10.94K | $154.25K |
 NTLA | Intellia Therapeutics, Inc. | 4.33% | 3.79K | $135.42K |
 IONS | Ionis Pharmaceuticals, Inc. | 4.10% | 3.55K | $128.19K |
 ARWR | Arrowhead Pharmaceuticals, Inc. | 3.68% | 3.85K | $115.07K |
 RNA | Avidity Biosciences, Inc. | 3.67% | 7.29K | $114.74K |
 CVAC | CureVac N.V. | 3.38% | 13.32K | $105.80K |
 DYN | Dyne Therapeutics, Inc. | 3.05% | 9.08K | $95.32K |
 ABUS | Arbutus Biopharma Corporation | 3.00% | 31.69K | $93.81K |
 SGMO | Sangamo Therapeutics, Inc. | 2.26% | 43.44K | $70.80K |
 STOK | Stoke Therapeutics, Inc. | 1.94% | 7.15K | $60.85K |
 PRQR | ProQR Therapeutics N.V. | 1.54% | 21.68K | $48.13K |
 PEPG | PepGen Inc. | 1.29% | 3.22K | $40.48K |
SECTOR HOLDINGS
Technology
Industrials
Healthcare
Consumer Cyclical
Consumer Defensive
Financial Services
Communication Services
Basic Materials
Real Estate
Energy
UtilitiesASSET ALLOCATION BY REGION
United States
Germany
NetherlandsSECTOR HOLDINGS
Technology Industrials Healthcare Consumer Cyclical Consumer Defensive Financial Services Communication Services Basic Materials Real Estate Energy UtilitiesASSET ALLOCATION BY REGION
United States Germany NetherlandsHoldings (Top 20)
VRTX
Vertex Pharmaceuticals Incorporated
ARCT
Arcturus Therapeutics Holdings Inc.
SCLX
Scilex Holding Company
ALNY
Alnylam Pharmaceuticals, Inc.
PTCT
PTC Therapeutics, Inc.
BNTX
BioNTech SE
MRNA
Moderna, Inc.
SRPT
Sarepta Therapeutics, Inc.
MRVI
Maravai LifeSciences Holdings, Inc.
NTLA
Intellia Therapeutics, Inc.
IONS
Ionis Pharmaceuticals, Inc.
ARWR
Arrowhead Pharmaceuticals, Inc.
RNA
Avidity Biosciences, Inc.
CVAC
CureVac N.V.
DYN
Dyne Therapeutics, Inc.
ABUS
Arbutus Biopharma Corporation
SGMO
Sangamo Therapeutics, Inc.
STOK
Stoke Therapeutics, Inc.
PRQR
ProQR Therapeutics N.V.
PEPG
PepGen Inc.